Human milk oligosaccharides to promote growth of beneficial bacteria

Abstract

Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, and children for improving gastrointestinal function and tolerance, as well as the growth of beneficial bacteria. Additional suitable methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation application of U.S. patent application Ser. No. 13 / 335,323 filed on Dec. 22, 2011, which claims the benefit of U.S. Provisional Application No. 61 / 428,867 filed on Dec. 31, 2010; and U.S. Provisional Application No. 61 / 474,691 filed on Apr. 12, 2011, which disclosures are incorporated by reference in their entirety.FIELD OF THE DISCLOSURE[0002]The present disclosure relates to human milk oligosaccharides (HMOs) for improving gastrointestinal function and tolerance in infants, toddlers, and children. More particularly, the present disclosure relates to human milk fortifiers, preterm and term infant formulas, and pediatric formulas comprising HMOs that can stimulate enteric nerve cells in the gastrointestinal tract, thereby treating and / or preventing numerous gastrointestinal-related conditions and diseases.BACKGROUND OF THE DISCLOSURE[0003]During postnatal development, a newborn's intestine experiences a ...

AI Technical Summary

Benefits of technology

[0006]The present disclosure is directed to nutritional compositions, including synthetic infant formulas, synthetic pediatric formulas, and synthetic child formulas including at least one HMO alone or in combination with other components such as prebiotic oligosaccharides and / or probiotics, for improving gut function and immunity in an infant, toddler, child, or adult, along with related methods of use. More particularly, the nutritional compositions can improve growth and maturation of the gut barrier, thereby treating and / or preventing formula intolerance or other gastrointestinal diseases and / or disorders resulting from a loss or dysfunction of the gut barrier.

Problems solved by technology

For very young infants, and particularly, preterm infants, who have an immature immune system and intestinal tract, development of suboptimal intestinal flora may result in infection, diarrhea, allergies, and food intolerance.

Not all infants, however, are in a position to receive human breast milk.

Images